Peptides: the next drug modality stack
A new drug modality is emerging — AI is accelerating design, GLP-1 proves demand, and manufacturing is becoming the bottleneck.
Demand & applications
Metabolic & obesity (GLP-1 proven)
Anchors
Core innovation
AI-driven design & discovery
Therapeutics platforms
Delivery & oral bioavailability
Discovery, screening & tools
Infrastructure & manufacturing
Scale-up (the bottleneck)